Macrophage phenotype and renal fibrosis in obstructive nephropathy

Nephron - Experimental Nephrology

Volumn 110, Issue 1, 2008, Pages

  Nishida, Masashi ^a   Hamaoka, Kenji ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Alternatively activated macrophage; Classically activated macrophage

Indexed keywords

CYCLOPHOSPHAMIDE; INTERLEUKIN 10; LOW MOLECULAR WEIGHT HEPARIN; MATRIX METALLOPROTEINASE 2 INHIBITOR; MATRIX METALLOPROTEINASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

APOPTOSIS; BONE MARROW TRANSPLANTATION; CELL COUNT; CELL HETEROGENEITY; CELL INFILTRATION; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; KIDNEY DISEASE; KIDNEY FIBROSIS; MACROPHAGE; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; URETER OBSTRUCTION;

ANIMALS; FIBROSIS; HUMANS; KIDNEY; KIDNEY DISEASES; MACROPHAGES; PHENOTYPE; URETERAL OBSTRUCTION;

EID: 49849099578     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151561     Document Type: Short Survey

References (29)

1. Eddy AA: Interstitial macrophages as mediators of renal fibrosis. Exp Nephrol 1995;3:76-79.
2. Schreiner GF, Harris KPG, Purkerson ML, Klahr S: Immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney. Kidney Int 1988;34:487-493.
3. Nishida M, Fujinaka H, Matsusaka T, Price J, Kon V, Fogo AB, Davidson JM, Linton MF, Fazio S, Homma T, Yoshida H, Ichikawa I: Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis. J Clin Invest 2002;110:1859-1868.
4. Zhang G, Kim H, Cai X, Lopez-Guisa JM, Carmeliet P, Eddy AA: Urokinase receptor modulates cellular and angiogenic responses in obstructive nephropathy. J Am Soc Nephrol 2003;14:1234-1253.
5. Cochrane AL, Kett MM, Samuel CS, Campanale NV, Anderson WP, Hume DA, Little MH, Bertram JF, Ricardo SD: Renal structural and functional repair in a mouse model of reversal of ureteral obstruction. J Am Soc Nephrol 2005;16:3623-3630.
6. Nishida M, Okumura Y, Fujimoto S, Shiraishi I, Itoi T, Hamaoka K: Adoptive transfer of macrophages ameliorates renal fibrosis in mice. Biochem Biophys Res Commun 2005;332:11-16.
7. Pecly IM, Gonçalves RG, Rangel EP, Takiya CM, Taboada FS, Martinusso CA, Pavão MSG, Leite M Jr: Effects of low molecular weight heparin in obstructed kidneys: decrease of collagen, fibronectin and TGF-β, and increase of chondroitin/dermatan sulfate proteoglycans and macrophage infiltration. Nephrol Dial Transplant 2006;21:1212-1222.
8. Nishida M, Okumura Y, Ozawa S, Shiraishi I, Itoi T, Hamaoka K: MMP-2 inhibition reduces renal macrophage infiltration with increased fibrosis in UUO. Biochem Biophys Res Commun 2007;354:133-139.
9. Duffield JS: The inflammatory macrophage: a story of Jekyll and Hyde. Clin Sci 2003;104:27-38.
10. Lupher Jr ML, Gallatin WM: Regulation of fibrosis by the immune system. Adv Immunol 2006;89:245-288.
11. Ferenbach D, Kluth DC, Hughes J: Inflammatory cells in renal injury and repair. Sem Nephrol 2007;27:250-259.
12. Wada T, Furuichi K, Sakai N, Iwata Y, Kitagawa K, Ishida Y, Kondo T, Hashimoto H, Ishiwata Y, Mukaida N, Tomosugi N, Matsushima K, Egashira K, Yokoyama H: Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. J Am Soc Nephrol 2004;15:940-948.
13. Sung SA, Jo SK, Cho WY, Won NH, Kim HK: Reduction of renal fibrosis as a result of liposome encapsulated clodronate induced macrophage depletion after unilateral ureteral obstruction in rats. Nephron Exp Nephrol 2007;105:e1-e9.
14. Goerdt S, Orfanos CE: Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999;10:137-142.
15. Duffield JS, Ware CF, Ryffel B, Savill J: Suppression by apoptotic cells defines tumor necrosis factor-mediated induction of glomerular mesangial cell apoptosis by activated macrophages. Am J Pathol 2001;158:1397-1404.
16. Kipari T, Hughes J: Macrophage-mediated renal cell death. Kidney Int 2002;61:760-761.
17. Lange-Sperandio B, Cachat F, Thornhill BA, Chevalier RL: Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice. 2002;61:516-524.
18. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM: Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 1998;101:890-898.
19. Song E, Ouyang N, Horbelt M, Antus B, Wang M, Exton MS: Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol 2000;204:19-28.
20. Gibbs DF, Warner RL, Weiss SJ, Johnson KJ, Varani J: Characterization of matrix metalloproteinases produced by rat alveolar macrophages. Am J Respir Cell Mol 1999;20:1136-1144.
21. Mariani TJ, Sandefur S, Robby JD, Pierce RA: Collagenase-3 induction in rat lung fibroblasts requires the combined effects of tumor necrosis factor-α and 12-lipoxygenase metabolites: a model of macrophage-induced, fibroblast-driven extracellular matrix remodeling during inflammatory lung injury. Mol Biol Cell 1998;9:1411-1424.
22. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, Hovell C, Arthur MJ: Mechanism of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998;102:538-549.
23. Cheng S, Lovett DH: Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation. Am J Pathol 2003;162:1937-1949.
24. Lutz J, Yao Y, Song E, Antus B, Hamar P, Liu S, Heemann U: Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats. Transplantation 2005;79:655-661.
25. Duffield JS, Forbes SJ, Constandinou CM, Clay S, Partolina M, Vuthoori S, Wu S, Lang R, Iredale JP: Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005;115:56-65.
26. Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, Haslett C, Simpson K, Sethi T: Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci USA 2006;103:5060-5065.
27. Henderson NC, Mackinnon AC, Farnworth SL, Kipari T, Haslett C, Iredale JP, Liu FT, Hughes J, Sethi T: Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol 2008;172:288-298.
28. Mackinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, Nilsson UJ, Haslett C, Forbes SJ, Sethi T: Regulation of alternative macrophage activation by galectin-3. J Immunol 2008;180:2650-2658.
29. Raes G, Noël W, Beschin A, Brys L, de Baetselier P, Hassanzadeh GH: FIZZ1 and Ym as tools to discriminate between differentially activated macrophages. Dev Immunol 2002;9:151-159.